During the past decade, CNRI-Los Angeles LLC conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 23 clinical trials were completed, i.e. on average, 85.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CNRI-Los Angeles LLC" #1 sponsor was "Sunovion" with 18 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 9 trials sponsored, "Cephalon" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Corcept Therapeutics" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CNRI-Los Angeles LLC" #1 collaborator was "H. Lundbeck A/S" with 5 trials as a collaborator and "Otsuka America Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CNRI-Los Angeles LLC" are "Schizophrenia" (39 trials), "Schizoaffective Disorder" (5 trials), "Major Depressive Disorder" (4 trials), "Bipolar Depression" (2 trials) and "Bipolar I Disorder" (2 trials). Many other conditions were trialed in "CNRI-Los Angeles LLC" in a lesser frequency.

Most popular intervention types in "CNRI-Los Angeles LLC" are "Drug" (60 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Lurasidone" (5 trials), "SEP-363856" (4 trials), "Lurasidone HCl" (3 trials) and "Quetiapine XR" (3 trials). Other intervention names were less common.

The vast majority of trials in "CNRI-Los Angeles LLC" are 61 trials for "All" genders.

Currently, there are NaN active trials in "CNRI-Los Angeles LLC". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in CNRI-Los Angeles LLC, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in CNRI-Los Angeles LLC, 7 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

CNRI-Los Angeles LLC has several departments that took part in Clinical trials: "California Neuropsychopharmacology,CNRI - Los Angeles LLC,8309 Telegraph Road" - 2 trials